Company
Galectin Therapeutics Inc (NASDAQ:GALT): Buy, Sell Or Hold At $3.97?
In last trading session, Galectin Therapeutics Inc (NASDAQ:GALT) saw 0.49 million shares changing hands with its beta currently measuring 0.78. Company’s recent per share price
